Skip to main content
. 2020 Oct 14;44(3):zsaa206. doi: 10.1093/sleep/zsaa206

Figure 2.

Figure 2.

Participant disposition. DBRWP, double-blind randomized withdrawal period; LXB, lower-sodium oxybate; OLOTTP, open-label optimized treatment and titration period; SDP, stable-dose period; SXB, sodium oxybate; TEAE, treatment-emergent adverse event.